Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base EPI-Net EPOXI Mpox NeoDeco Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training 19.10.2022 ECRAID-Base: An exemplary collaboration in European clinical research Complex and multi-faceted, the project is split into 13 ‘work packages’, each one coordinated by a dedicated team. 13.10.2022 LAB-Net increases activities in POS-VAP LAB-Net plays a key role in the site selection process in most ECRAID-Base studies, including POS-VAP. 14.09.2022 POS-ARI-ER publication: A closer look at respiratory support failure in COVID-19 patients Study describes characteristics, outcomes and risk factors for failing non-invasive respiratory support in COVID-19 patients. 13.09.2022 Pandemic preparedness: Fighting antimicrobial resistance in the community Chris Butler on tackling AMR in the community setting 12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva. 6.09.2022 Pablo Martínez Aguado’s quest for prioritising wellbeing in research Pablo Martínez Aguado is a project manager for Ecraid’s POS-cUTI study. We spoke to him about his invaluable time working and le… Load More
19.10.2022 ECRAID-Base: An exemplary collaboration in European clinical research Complex and multi-faceted, the project is split into 13 ‘work packages’, each one coordinated by a dedicated team.
13.10.2022 LAB-Net increases activities in POS-VAP LAB-Net plays a key role in the site selection process in most ECRAID-Base studies, including POS-VAP.
14.09.2022 POS-ARI-ER publication: A closer look at respiratory support failure in COVID-19 patients Study describes characteristics, outcomes and risk factors for failing non-invasive respiratory support in COVID-19 patients.
13.09.2022 Pandemic preparedness: Fighting antimicrobial resistance in the community Chris Butler on tackling AMR in the community setting
12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva.
6.09.2022 Pablo Martínez Aguado’s quest for prioritising wellbeing in research Pablo Martínez Aguado is a project manager for Ecraid’s POS-cUTI study. We spoke to him about his invaluable time working and le…
